You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Drugs in MeSH Category Cross-Linking Reagents


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teyro Labs CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077861-002 Jan 18, 2007 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Rk Pharma MITOMYCIN mitomycin INJECTABLE;INJECTION 202670-002 Oct 13, 2017 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Novast Labs CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 208487-003 Apr 26, 2017 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.